DoD Breast Cancer Era of Hope Scholar Award | Apply Online

FAQs: DoD Breast Cancer Era of Hope Scholar Award (W81XWH-13-BCRP-EOHS)

1) What is the DoD Breast Cancer Era of Hope Scholar Award?

The DoD Breast Cancer Era of Hope Scholar Award is a U.S. Army (USAMRAA-managed) funding opportunity within the Congressionally Directed Medical Research Programs (CDMRP) Breast Cancer Research Program. It supports early-career researchers who demonstrate unusually high creativity, vision, and productivity, with the larger goal of accelerating progress toward ending breast cancer.

2) What is the Funding Opportunity Number for this award?

The Funding Opportunity Number is W81XWH-13-BCRP-EOHS.

3) Who manages this funding opportunity?

This opportunity is managed by the U.S. Army through USAMRAA under the CDMRP Breast Cancer Research Program.

4) What does the award mainly focus on: the project or the person?

This award is centered on the person leading the work. Rather than being driven primarily by a narrowly defined project concept, the main emphasis is on the Principal Investigator (PI) and their ability to deliver an innovative, potentially field-shifting contribution to breast cancer research.

5) What kind of scientific approach is the program looking for?

Reviewers are looking for a clear, compelling scientific vision that challenges current dogma and shows a willingness to move beyond traditional approaches. The program emphasizes bold, innovative thinking that could shift the field.

6) Who is the intended applicant profile?

The award is designed for early-career researchers who stand out as "best and brightest" scientists, with demonstrated momentum and the potential to become influential leaders in the breast cancer research community. Evidence of extraordinary creativity and a strong track record are important.

7) Is prior experience in breast cancer research required?

No. Prior experience working specifically in breast cancer is not required. The opportunity explicitly welcomes exceptional investigators from adjacent fields who can bring fresh perspectives, new technologies, or unconventional frameworks into breast cancer research.

8) Even if prior breast cancer experience is not required, does the application need to be breast cancer-focused?

Yes. Even though applicants may come from outside the breast cancer field, the application itself must be focused on breast cancer.

9) What level of effort is required from the Principal Investigator?

The PI must commit at least 50 percent of their full-time professional effort during the award period to breast cancer research. This indicates the award is intended to support a major professional focus rather than a side project.

10) Are collaborations and partnerships important for this award?

Yes. The opportunity explicitly values researchers who can build effective partnerships and collaborations. The program reflects an expectation that high-impact advances often require cross-disciplinary teamwork and the ability to connect different areas of expertise.

11) What is the program area within CDMRP?

This award is part of the CDMRP Breast Cancer Research Program.

12) What is the funding mechanism and activity category?

The funding mechanism is listed as a cooperative agreement/grant. The activity category is Science and Technology and other Research and Development.

13) When was this opportunity posted, and what were the key dates?

The opportunity was posted on May 10, 2013. The closing date was July 2, 2013, and the archive date was August 1, 2013.

14) What is the CFDA number associated with this opportunity?

The CFDA number is 12.420 (Military Medical Research and Development).

15) Is cost sharing or matching required?

No. The opportunity states there is no cost sharing or matching requirement.

16) Who is eligible to apply?

Eligibility is described as unrestricted, meaning it is open to any type of entity, subject to any additional eligibility clarifications contained in the full announcement.

17) How much funding is available and how many awards are expected?

The estimated total funding amount is listed as 50 (as provided in the source data), with an expected three awards.

18) Where can applicants get help accessing the complete announcement?

Applicants or institutions needing assistance accessing the complete announcement can contact the CDMRP Help Desk by phone at 301-682-5507 or by email at help@cdmrp.org.

19) What is the broader goal of the award?

The broader goal is to accelerate progress toward ending breast cancer by supporting unusually creative and visionary early-career researchers who can generate bold ideas and translate them into impactful research.

20) What will reviewers look for in the PI?

Reviewers are looking for evidence of extraordinary creativity, strong momentum, a track record suggesting the ability to generate bold ideas and translate them into impactful research, and the potential to become an influential leader in the breast cancer research community.